Pharmaceutical and healthcare market
Pharmaceutical market research
Reliable data and well-founded insights for better decision-making in the healthcare market
Market research in the pharmaceutical and
healthcare sector
Reliable data for better decision-making in the healthcare market
IFAK Pharmaceutical Market Research
IFAK Health & Pharma specialises in pharmaceutical market research that really makes a difference – providing in-depth insights into the motivations, attitudes and needs of doctors, other healthcare professionals, patients, carers and other target groups in the healthcare sector.
IFAK – your experts in...
Key target groups & rare diseases
Potential estimates
Patient case records
As an experienced full-service specialist, we develop bespoke study designs that provide precise answers to your specific research questions. In this way, we provide a solid basis for decision-making that strengthens your marketing in the healthcare market.
Get in touch now.
Our pharmaceutical experts look forward to hearing from you.
Data protection: By clicking ‘Submit’, you consent to the storage and processing of your data.
IFAK’s specialist expertise in pharmaceutical market research
Key target groups
Key target groups are highly specialised and often hard-to-reach stakeholders in the healthcare market – such as medical specialists, opinion leaders or rare patient groups. An in-depth understanding of their perspectives, needs and decision-making processes is essential for gaining valid and relevant insights.
Potential estimates
How big is the market for your product really? Which patient groups are not yet receiving optimal care? And where does the untapped prescribing potential lie amongst your target groups? With our potential assessment, you won’t receive gut-feel estimates – but rather reliable data to underpin your strategic decisions. Whether it’s market entry, lifecycle management or indication expansion – we provide you with the insights you need to allocate budgets effectively and identify opportunities before your competitors do.
Moment of Truth – Motives at the Moment of Prescription
What actually happens in practice when your medicine is prescribed? Which patients are treated with medicine X and which with medicine Y? Patient case reports, in which the doctor documents the reasons for their choice, provide you with precisely these answers: taken directly from everyday clinical practice, in a structured format and ready for analysis.
Who are we conducting research for?
Through many years of collaboration and close customer relationships, we have gained extensive market knowledge in the following sectors and can tell you exactly what your target audiences want.
Pharmaceutical industry
- RX
- OTC
- Phytopharmaceuticals/herbal medicines
- Dietary supplements
Healthcare system & institutions
- Healthcare organisations
- Associations
- Self-help groups
Medical Technology & Life Sciences
- Manufacturers of diagnostic and therapeutic devices
- Orthoses and prostheses
- Monitoring and digital medtech
- Drug delivery systems
Research & Communication
- Medical publishers
- Clinical research organisations (CROs)
- Institutes for continuing medical education
Reference selection from pharmaceutical market research
Further fields of research at IFAK Pharmaceutical Market Research
Physicians, patients and other stakeholders in the healthcare market
How do physicians, pharmacists, patients and other stakeholders in the healthcare market behave? What are their needs and expectations? What trends shape their decision-making behaviour?
- Target group segmentation
- Indication- and therapy-related target group research
- Usage and attitude studies in the healthcare context
Healthcare Markets & Touchpoints
How are markets in the pharmaceutical sector evolving? Through which channels can I best reach my target groups? Which touchpoints are particularly relevant along the patient, pharmacy buyer or HCP journey?
- Customer Experience in Healthcare
- Patient & HCP Journey Analyses
- Surveys at the point of care (e.g. practice staff, pharmacists & pharmacy technicians)
- Satisfaction levels among patients, doctors and partners
Therapies, Products & Services
Which therapeutic approaches and product ideas are most convincing? How well do they meet the needs of patients and healthcare professionals? What level of price acceptance exists within the regulated environment?
- Innovation research in the pharmaceutical and healthcare sectors
- Concept and prototype testing (e.g. medicines, devices, services)
- Product and treatment evaluations
- Usage and acceptance testing (e.g. dosage forms)
- Pricing research
Pharmaceutical Marketing & Positioning
How is my product or company positioned in the healthcare market? How can I differentiate myself from the competition? How can I achieve sustainable growth?
- Brand awareness in the pharmaceutical and healthcare sectors
- Positioning and differentiation studies
- The impact of advertising on patients and healthcare professionals
- Image and reputation studies
Insider tips from pharmaceutical market research
01
Positioning research: How do doctors perceive a medicinal product?
Without market positioning, there can be no successful brand. But how can a pharmaceutical company achieve this, and what scientific insights can help along the way? Dr Ulrike Dulinski, Head of Health & Pharma at IFAK Institut GmbH & Co. KG, has the answers.
02
New perspectives on the medicine of tomorrow: The Gen Z Doctors’ Blog
With this blog dedicated to the younger generation of doctors, a new and important voice has gained prominence in the debate on health policy. Dr Ulrike Dulinski
examines the changes within the medical profession in a nuanced, data-driven and, at the same time, deliberately provocative manner.
03
Doctors’ prescribing behaviour
Would you like to gain insights into doctors’ prescribing behaviour? If so, we recommend the article by Dr Ulrike Dulinski in *planung & analyse*. The article examines a methodological approach that provides surprising insights into doctors’ prescribing behaviour.
Your contacts at IFAK Pharma Market Research
Dr. Ulrike Dulinski
Head of Health & Pharma
